Author

M. The

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Rosenwald· 1 shared A. Sakhteman· 1 shared B. Kuster· 1 shared B. Küster· 1 shared B. Meyer· 1 shared C. Halves· 1 shared C. Mogler· 1 shared F. Fusco· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Rosenwald

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Towards routine proteome profiling of FFPE tissue: Insights from a 1,200 case pan-cancer study

J. Tueshaus, S. Eckert, M. Fraefel, Y. Zhou, P. Pfeiffer, C. Halves, F. Fusco, J. Weigl, L. Hönikl, V. Butenschön, R. Todorova, H. Rauert-Wunderlich, M. The, A. Rosenwald, V. Heinemann, , B. Küster

The paper profiles proteomes from 1,220 FFPE tumors across six cancers, identifies a new normalization method, and reports a comprehensive pan-cancer proteome resource.

bioRxiv · Jun 21, 2024Pathology

Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response

S. Hofer, L. Frasch, K. Putzker, J. Lewis, A. Sakhteman, M. The, F. P. Bayer, J. Muller, F. Hamood, B. Kuster

This study identifies ATR inhibitors as synergistic with gemcitabine in killing PDAC cells by blocking the DNA damage response pathway.

bioRxiv · Mar 22, 2024Cancer Biology